PURPOSE: To assess visual outcomes at different distances, refraction and safety profile of the enVista ENVY full visual range intraocular lens following cataract surgery.

METHODS: A single U.S. surgeon implanted the enVista ENVY (EN) and the enVista ENVY toric (ETN) IOLs in 49 patients (71 eyes) between November 6, 2024, and July 30, 2025. This case series assesses postoperative performance at distance, intermediate and near vision, mean refractive spherical equivalent (MRSE), and occurrence of glistenings, posterior capsule opacification (PCO), and adverse events (AEs).

RESULTS: 28 eyes were implanted with EN and 43 eyes with ETN, with a mean±SD target SE of –0.23±0.16 (n=27) and –0.19±0.13, respectively. Monocular CDVA ≤20/25 was achieved in 100% (EN) and 95% (ETN); UDVA ≤20/32 in 86% and 77%; UIVA ≤20/25 in 95% and 84%; and UNVA ≤ J2 in 79% and 76%, respectively. Binocular CDVA ≤20/25 was achieved in 100% (EN) and 92% (ETN). Mean±SD MRSE and residual cylinder were –0.06±0.40 and –0.36±0.28 (EN), and –0.32±0.32 and –0.40±0.35 (ETN). No serious AEs or glistenings were observed.

CONCLUSION: enVista ENVY provided excellent refractive accuracy and a high visual performance at distance, intermediate and near, with no serious AEs or glistenings reported.